- Published at
- by rakesh-jhunjhunwala.in
mixed
mixed
Glenmark Life Sciences has proven execution capabilities, strong financials and long-term expansion plans. Buy for target price of ₹1040 (29% upside): ICICI Direct
We have assigned BUY rating on GLS, on the back of proven execution capabilities, strong financials and long-term expansion plans in APIs and CDMO. We believe the change of ownership could be benef…